Quarterly report · Q2
4570.TEDINET S100PKP5
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥293m | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥648m | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥254m | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | −¥55m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | −¥137m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | −¥130m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥243m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥188m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥132m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥195m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥136m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥259m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥199m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥136m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | −¥199m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥329m | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥337m | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥406m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥508m | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥341m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥449m | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥546m | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥552m | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥51m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥93m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥100m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥64m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥156m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥39m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥3m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥144m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥132m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-14.62 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.29 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-27.78 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.4 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-9.51 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 78.9% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.8% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 25
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥8m |
| jpcrp040300-q2r_E00986-000Gene Recombination Silkworm Developmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥41m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥291m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥291m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥6m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥293m |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥293m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | −¥55m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥3m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | ¥480,000 |
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥10m |
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥10m |
| jpcrp040300-q2r_E00986-000Cosmeticsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥5m |
| jpcrp040300-q2r_E00986-000Gene Recombination Silkworm Developmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥53m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥247m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥244m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥3m |
| jpcrp040300-q2r_E00986-000Immunity Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥79m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥257m |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥254m |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥3m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | −¥137m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 431
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 1123700 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1207 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 229400 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0246 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 214500 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0230 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 205000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0220 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 140500 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0151 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 101600 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0109 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 100000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0107 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 97369 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0105 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 94300 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0101 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 88900 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0095 | |
| Number of shares held | CurrentQuarterInstant | 2395269 | |
| Shareholding ratio | CurrentQuarterInstant | 0.2572 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 1100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 9308200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 93082 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 5290 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 9314590 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 93082 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 1100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 1100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0001 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 1100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 1100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0001 | |
| Cash and deposits | Prior1YearInstant | 508350000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 405961000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 173869000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 151409000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 47380000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 46125000 | JPY |
| Work in process | Prior1YearInstant | 133314000 | JPY |
| Work in process | CurrentQuarterInstant | 144907000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 145892000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 155951000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |